| Kathryn Tetreault, CRNA | |
|
7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808-4300 | |
| (225) 214-6438 | |
| (225) 214-6438 |
| Full Name | Kathryn Tetreault |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 7777 Hennessy Blvd, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053852806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP09234 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesiology Group Associates Inc | 0042110298 | 151 |
News Archive
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease.
Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelonahave participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA.
› Verified 9 days ago
| Entity Name | Anesthesiology Group Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255399598 PECOS PAC ID: 0042110298 Enrollment ID: O20040113000117 |
News Archive
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease.
Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelonahave participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA.
› Verified 9 days ago
| Entity Name | Total Anesthesia Care Stph Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669475190 PECOS PAC ID: 0749255909 Enrollment ID: O20040831000877 |
News Archive
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease.
Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelonahave participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA.
› Verified 9 days ago
| Entity Name | Youngs Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20070226000608 |
News Archive
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease.
Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelonahave participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA.
› Verified 9 days ago
| Entity Name | Diversified Professionals, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700923992 PECOS PAC ID: 0446356463 Enrollment ID: O20070507000647 |
News Archive
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease.
Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelonahave participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA.
› Verified 9 days ago
| Entity Name | North Oaks Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972630705 PECOS PAC ID: 2466629522 Enrollment ID: O20120117000359 |
News Archive
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease.
Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelonahave participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA.
› Verified 9 days ago
| Entity Name | Gastroenterology Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699089581 PECOS PAC ID: 5890955264 Enrollment ID: O20130514000265 |
News Archive
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease.
Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelonahave participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA.
› Verified 9 days ago
| Entity Name | Symvios Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427746619 PECOS PAC ID: 8729446521 Enrollment ID: O20230627002071 |
News Archive
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease.
Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelonahave participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Tetreault, CRNA 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808-4300 Ph: (225) 214-6438 | Kathryn Tetreault, CRNA 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808-4300 Ph: (225) 214-6438 |
News Archive
Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease.
Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Company's PARADISE System—the only system for renal denervation that is based on ultrasound, not radiofrequency, energy.
Researchers from the research group in growth factors and cell differentiation at IDIBELL and the University of Barcelonahave participated in an international study that has identified the genetic cause of developmental delay observed in Amish individuals in the USA.
› Verified 9 days ago
Toni Tolar, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8325 Kelwood Ave, Baton Rouge, LA 70806 Phone: 225-929-7600 Fax: 225-930-7524 | |
Holli B Cordell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-769-4403 Fax: 225-769-4403 | |
Amy Johnson, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808 Phone: 225-214-6438 | |
Mrs. Courtney Day Passman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-765-3111 Fax: 225-765-3114 | |
Denise N Baumgartner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 8212 Summa Ave, Baton Rouge, LA 70809 Phone: 225-769-4403 Fax: 225-769-3842 | |
Kaley Mcclure, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-8541 | |
Alton J Ardoin, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 7855 Howell Blvd, Baton Rouge, LA 70807 Phone: 225-358-4900 |